The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou, Christina; ÖZDEMİR, Ramazan; Pfister, Roman; Bergmann, Martin; Bartunek, Jozef; KILIÇ, TEOMAN; Lauten, Alexander; Schmeisser, Alexander; ZOGHİ, MEHDİ; Anker, Stefan; Sievert, Horst; Mahfoud, Felix

doi:10.4244/eij-d-19-00342

The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction

Paitazoglou C., ÖZDEMİR R., Pfister R., Bergmann M. W., Bartunek J., KILIÇ T., ...Daha Fazla

EUROINTERVENTION, cilt.15, sa.5, ss.403-410, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 15 Sayı: 5
Basım Tarihi: 2019
Doi Numarası: 10.4244/eij-d-19-00342
Dergi Adı: EUROINTERVENTION
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.403-410
Anahtar Kelimeler: atrial septal defect, chronic heart failure, clinical trials, innovation, DIASTOLIC FUNCTION, INTERATRIAL SHUNT, LAP-HF, DIAGNOSIS, PRESSURE, ECHOCARDIOGRAPHY, EXERCISE, SOCIETY, DEVICE, ADULT
Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Aims: Reducing elevated left atrial pressure with an atrial septum shunt device is a possible treatment option in symptomatic heart failure patients. This study aimed to investigate the safety and feasibility of the Atrial Flow Regulator (AFR) in heart failure patients.